Squarepoint Ops LLC Ab Cellera Biologics Inc. Transaction History

Squarepoint Ops LLC

  • $96.1 Billion
  • Q3 2025

A detailed history of Squarepoint Ops LLC transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 102,471 shares of ABCL stock, worth $378,117. This represents 0.0% of its overall portfolio holdings.

Number of Shares
102,471
Previous 14,319 615.63%
Holding current value
$378,117
Previous $49,000 951.02%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$3.49 - $5.15 $307,650 - $453,982
88,152 Added 615.63%
102,471 $515,000
Q2 2025

Aug 27, 2025
SELL
$1.93 - $3.8 $8,551 - $16,837
-4,431 Reduced 23.63%
14,319 $49,000
Q2 2025

Aug 14, 2025
SELL
$1.93 - $3.8 $8,551 - $16,837
-4,431 Reduced 23.63%
14,319 $49,000
Q1 2025

Aug 27, 2025
BUY
$2.2 - $3.53 $9,748 - $15,641
4,431 Added 30.94%
18,750 $41,000
Q1 2025

May 15, 2025
SELL
$2.2 - $3.53 $85,657 - $137,440
-38,935 Reduced 67.5%
18,750 $41,000
Q4 2024

Feb 14, 2025
BUY
$2.48 - $3.15 $110,030 - $139,756
44,367 Added 333.14%
57,685 $169,000
Q3 2024

Nov 14, 2024
SELL
$2.39 - $3.49 $132,860 - $194,009
-55,590 Reduced 80.67%
13,318 $34,000
Q2 2024

Aug 14, 2024
BUY
$2.73 - $4.73 $60,420 - $104,684
22,132 Added 47.31%
68,908 $203,000
Q1 2024

May 15, 2024
SELL
$4.29 - $5.97 $22,440 - $31,229
-5,231 Reduced 10.06%
46,776 $211,000
Q4 2023

Feb 14, 2024
SELL
$3.91 - $5.93 $283,009 - $429,219
-72,381 Reduced 58.19%
52,007 $296,000
Q2 2023

Aug 14, 2023
SELL
$5.66 - $7.59 $192,660 - $258,356
-34,039 Reduced 21.49%
124,388 $803,000
Q1 2023

May 15, 2023
SELL
$7.31 - $11.18 $286,149 - $437,641
-39,145 Reduced 19.81%
158,427 $1.19 Million
Q4 2022

Feb 14, 2023
BUY
$9.48 - $14.52 $1.41 Million - $2.16 Million
148,779 Added 304.92%
197,572 $2 Million
Q3 2022

Nov 14, 2022
SELL
$9.2 - $13.68 $695,244 - $1.03 Million
-75,570 Reduced 60.77%
48,793 $483,000
Q2 2022

Aug 15, 2022
SELL
$5.72 - $10.65 $357,191 - $665,049
-62,446 Reduced 33.43%
124,363 $1.32 Million
Q1 2022

May 16, 2022
BUY
$7.46 - $14.14 $794,698 - $1.51 Million
106,528 Added 132.69%
186,809 $1.82 Million
Q4 2021

Feb 14, 2022
BUY
$12.99 - $17.73 $308,460 - $421,016
23,746 Added 42.0%
80,281 $1.15 Million
Q3 2021

Nov 15, 2021
BUY
$14.85 - $21.34 $492,886 - $708,295
33,191 Added 142.18%
56,535 $1.13 Million
Q2 2021

Aug 16, 2021
BUY
$20.19 - $34.17 $155,119 - $262,528
7,683 Added 49.06%
23,344 $514,000
Q1 2021

May 17, 2021
BUY
$23.29 - $53.2 $364,744 - $833,165
15,661 New
15,661 $532,000

Others Institutions Holding ABCL

# of Institutions
169
Shares Held
109M
Call Options Held
1.26M
Put Options Held
788K
View Full List

About AbCellera Biologics Inc.

ABCL Quotes by TradingView
  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $1.05B
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email